Osaki, Yukio

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Sangro, B., Chan, S. L., Kelley, R. K., Lau, G., Kudo, M., Sukeepaisarnjaroen, W., Yarchoan, M., De Toni, E. N., Furuse, J., Kang, Y. K., et al. (2024) · Annals of Oncology

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 365

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma

Yoshida, H., Shiratori, Y., Kudo, M., Shiina, S., Mizuta, T., Kojiro, M., Yamamoto, K., Koike, Y., Saito, K., Koyanagi, N., et al. (2011) · Hepatology

Vitamin K Research StudiesHepatocellular Carcinoma Treatment and Prognosis

Cited by 127

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study

Peretinoin Study Group, Okita, K., Izumi, N., Matsui, O., Tanaka, K., Kaneko, S., Moriwaki, H., Ikeda, K., Osaki, Y., Numata, K., et al. (2015) · Journal of Gastroenterology

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus research

Cited by 90

Serum levels of α-fetoprotein increased more than 10 Years before detection of hepatocellular carcinoma

Hughes, D. M., Berhane, S., Emily de Groot, C. A., Toyoda, H., Tada, T., Kumada, T., Satomura, S., Nishida, N., Kudo, M., Kimura, T., et al. (2021) · Clinical Gastroenterology and Hepatology

Hepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and Treatment

Cited by 39

First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience

SAWASAKI, M., TSUBAMOTO, H., SUGIHARA, A., IKUTA, S., SAKAI, Y., OSAKI, Y., & SONODA, T. (2022) · Anticancer Research

Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology

Cited by 7